scispace - formally typeset
C

Carmen Fernandez-Becerra

Researcher at University of Barcelona

Publications -  71
Citations -  3421

Carmen Fernandez-Becerra is an academic researcher from University of Barcelona. The author has contributed to research in topics: Plasmodium vivax & Malaria. The author has an hindex of 27, co-authored 64 publications receiving 2864 citations. Previous affiliations of Carmen Fernandez-Becerra include University of Granada & University of São Paulo.

Papers
More filters
Journal ArticleDOI

Comparative genomics of the neglected human malaria parasite Plasmodium vivax

TL;DR: The synteny and isochore structure of P. vivax chromosomes are described, and it is shown that the parasite resembles other malaria parasites in gene content and metabolic potential, but possesses novel gene families and potential alternative invasion pathways not recognized previously.
Journal ArticleDOI

A superfamily of variant genes encoded in the subtelomeric region of Plasmodium vivax

TL;DR: Vir genes are identified, through the analysis of a continuous 155,711-base-pair sequence of a P. vivax chromosome end, a multigene family called vir, which is specific to P.vivax, indicating that they may have a functional role in establishing chronic infection through antigenic variation.
Journal ArticleDOI

Extracellular vesicles in parasitic diseases

TL;DR: This review provides the most relevant findings of the involvement of EVs in intercellular communication, modulation of immune responses, involvement in pathology, and their potential as new diagnostic tools and therapeutic agents in some of the major human parasitic pathogens.
Journal ArticleDOI

Size-exclusion chromatography as a stand-alone methodology identifies novel markers in mass spectrometry analyses of plasma-derived vesicles from healthy individuals.

TL;DR: The results support the use of SEC as a stand-alone methodology to obtain preparations of extracellular vesicles, in the size range of exosomes, from plasma and suggest theuse of CD5L and LGALS3BP as more suitable markers of plasma-derived vesicle markers in MS.